Abstract

Prednisolone 1 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: May/Jun 2020 - Volume 24, Number 3

Page(s): 229

Download in electronic PDF format for $75

Abstract

A formulation for preparing Prednisolone 1 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2020 Pg. 229	Prednisolone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 487	Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 386-389	Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Author(s): Williams LaVonn A, Fokken Dawn
Jan/Feb 2004 Pg. 46-48	Basics of Compounding for Disorders of the External Ear Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Mar/Apr 2004 Pg. 101-105	Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Jul/Aug 2011 Pg. 340	Methylprednisolone 4-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 302-307	Treating Inner Ear Disorders with Intratympanic Drug Administration Author(s): McElhiney Linda F
Jul/Aug 2005 Pg. 275-278	Compounding for Endocrine Disorders in Adult Patients Author(s): Grajeda Betty Jo, Vail Jane
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 1997 Pg. 87-89	Attention Deficit Hyperactivity Disorder Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 315	Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 417	Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 491	Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 225	Dexamethasone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 171-173	Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
Nov/Dec 1999 Pg. 496-500	Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Author(s): Goodwin Donald A, Fuhram L Clifton
Jan/Feb 2007 Pg. 78	Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 57	Sodium Citrate 9% Nasal Spray for Olfactory Disorders Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 490	Sulfasalazine 100 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr